Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
AbstractTyrosine kinases (TKs) play an important role in pathways that regulate cancer cell proliferation, apoptosis, angiogenesis and metastasis. Aberrant activity of TKs has been implicated in several types of cancers. In recent years, tyrosine kinase inhibitors (TKIs) have been developed to interfere with the activity of deregulated kinases. These TKIs are remarkably effective in the treatment of various human cancers including head and neck, gastric, prostate and breast cancer and several types of leukemia. However, these TKIs are transported out of the cell by ATP-binding cassette (ABC) transporters, resulting in development of a characteristic drug resistance phenotype in cancer patients. Interestingly, some of these TKIs also inhibit the ABC transporter mediated multi drug resistance (MDR) thereby; enhancing the efficacy of conventional chemotherapeutic drugs. This review discusses the clinically relevant TKIs and their interaction with ABC drug transporters in modulating MDR. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Anreddy, N.; Gupta, P.; Kathawala, R.J.; Patel, A.; Wurpel, J.N.D.; Chen, Z.-S. Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance. Molecules 2014, 19, 13848-13877.
Anreddy N, Gupta P, Kathawala RJ, Patel A, Wurpel JND, Chen Z-S. Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance. Molecules. 2014; 19(9):13848-13877.Chicago/Turabian Style
Anreddy, Nagaraju; Gupta, Pranav; Kathawala, Rishil J.; Patel, Atish; Wurpel, John N.D.; Chen, Zhe-Sheng. 2014. "Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance." Molecules 19, no. 9: 13848-13877.